 Vijaya Vemulakonda
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urologic Surgical Procedures | 17 | 2025 | 118 | 4.010 |
Why?
| | Ureteral Obstruction | 7 | 2024 | 65 | 3.960 |
Why?
| | Hydronephrosis | 7 | 2024 | 37 | 2.750 |
Why?
| | Urology | 8 | 2024 | 63 | 2.270 |
Why?
| | Kidney Pelvis | 4 | 2024 | 23 | 1.780 |
Why?
| | Vesico-Ureteral Reflux | 5 | 2024 | 36 | 1.630 |
Why?
| | Urinary Bladder | 6 | 2022 | 194 | 1.560 |
Why?
| | Renal Insufficiency | 3 | 2025 | 170 | 1.520 |
Why?
| | Electronic Health Records | 6 | 2022 | 1129 | 1.490 |
Why?
| | Fetal Diseases | 2 | 2022 | 180 | 1.330 |
Why?
| | Kidney | 7 | 2025 | 1482 | 1.270 |
Why?
| | Urogenital Abnormalities | 5 | 2025 | 71 | 1.200 |
Why?
| | Infant | 28 | 2026 | 9820 | 1.110 |
Why?
| | Urinary Tract Infections | 5 | 2025 | 195 | 1.050 |
Why?
| | Pediatrics | 4 | 2019 | 1102 | 0.960 |
Why?
| | Urethral Diseases | 3 | 2022 | 19 | 0.940 |
Why?
| | Urinary Tract | 2 | 2024 | 51 | 0.920 |
Why?
| | Decision Making | 3 | 2024 | 949 | 0.850 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1336 | 0.820 |
Why?
| | Child | 39 | 2026 | 22390 | 0.820 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 122 | 0.810 |
Why?
| | Kidney Transplantation | 3 | 2026 | 680 | 0.810 |
Why?
| | Urologists | 2 | 2020 | 17 | 0.760 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.750 |
Why?
| | Amniotic Fluid | 1 | 2022 | 79 | 0.730 |
Why?
| | Intermittent Urethral Catheterization | 2 | 2026 | 10 | 0.730 |
Why?
| | Urologic Diseases | 3 | 2018 | 40 | 0.690 |
Why?
| | Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.680 |
Why?
| | Kidney Diseases, Cystic | 1 | 2020 | 25 | 0.670 |
Why?
| | Child, Preschool | 24 | 2026 | 11511 | 0.660 |
Why?
| | Hypospadias | 2 | 2018 | 31 | 0.660 |
Why?
| | Urinary Bladder, Neurogenic | 5 | 2022 | 39 | 0.650 |
Why?
| | Ultrasonography, Prenatal | 5 | 2022 | 291 | 0.650 |
Why?
| | Documentation | 1 | 2022 | 194 | 0.640 |
Why?
| | Biomedical Research | 2 | 2018 | 684 | 0.630 |
Why?
| | Humans | 63 | 2026 | 141284 | 0.610 |
Why?
| | Qualitative Research | 5 | 2022 | 1519 | 0.570 |
Why?
| | Stakeholder Participation | 1 | 2019 | 80 | 0.570 |
Why?
| | Fasting | 1 | 2020 | 283 | 0.570 |
Why?
| | Neurotoxicity Syndromes | 1 | 2018 | 39 | 0.560 |
Why?
| | Urinary Incontinence | 2 | 2016 | 66 | 0.560 |
Why?
| | Postnatal Care | 2 | 2015 | 73 | 0.550 |
Why?
| | Preoperative Care | 1 | 2020 | 372 | 0.540 |
Why?
| | Parents | 3 | 2023 | 1439 | 0.540 |
Why?
| | Urinary Fistula | 1 | 2017 | 9 | 0.530 |
Why?
| | Retrospective Studies | 25 | 2026 | 16447 | 0.520 |
Why?
| | Prenatal Diagnosis | 2 | 2020 | 190 | 0.520 |
Why?
| | Epispadias | 1 | 2016 | 4 | 0.500 |
Why?
| | Bladder Exstrophy | 1 | 2016 | 17 | 0.500 |
Why?
| | Outpatients | 1 | 2020 | 425 | 0.500 |
Why?
| | Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.500 |
Why?
| | Female | 40 | 2026 | 75814 | 0.490 |
Why?
| | Urogenital System | 1 | 2016 | 17 | 0.490 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 341 | 0.480 |
Why?
| | Infant, Newborn | 12 | 2025 | 6270 | 0.480 |
Why?
| | Kidney Failure, Chronic | 1 | 2022 | 599 | 0.470 |
Why?
| | Risk Assessment | 5 | 2024 | 3522 | 0.460 |
Why?
| | Spinal Dysraphism | 2 | 2017 | 107 | 0.460 |
Why?
| | Appointments and Schedules | 2 | 2014 | 102 | 0.460 |
Why?
| | Anesthesia | 1 | 2018 | 248 | 0.440 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2008 | 255 | 0.440 |
Why?
| | Cultural Diversity | 2 | 2022 | 87 | 0.430 |
Why?
| | Hernia, Umbilical | 1 | 2014 | 20 | 0.410 |
Why?
| | Anus, Imperforate | 1 | 2014 | 24 | 0.410 |
Why?
| | Urethra | 1 | 2014 | 56 | 0.400 |
Why?
| | Male | 36 | 2026 | 70140 | 0.400 |
Why?
| | Internship and Residency | 4 | 2024 | 1230 | 0.390 |
Why?
| | Wilms Tumor | 1 | 2013 | 84 | 0.380 |
Why?
| | Tumor Burden | 1 | 2013 | 314 | 0.370 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2012 | 76 | 0.360 |
Why?
| | Patient Selection | 1 | 2015 | 685 | 0.350 |
Why?
| | Referral and Consultation | 1 | 2017 | 802 | 0.350 |
Why?
| | Physicians | 1 | 2020 | 930 | 0.350 |
Why?
| | Data Collection | 1 | 2014 | 655 | 0.340 |
Why?
| | Botulinum Toxins, Type A | 3 | 2011 | 55 | 0.340 |
Why?
| | Scoliosis | 1 | 2014 | 220 | 0.340 |
Why?
| | Ultrasonography | 4 | 2025 | 765 | 0.330 |
Why?
| | Adolescent | 18 | 2026 | 22116 | 0.330 |
Why?
| | Pregnancy | 5 | 2024 | 7035 | 0.310 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1610 | 0.300 |
Why?
| | Tertiary Care Centers | 3 | 2019 | 181 | 0.300 |
Why?
| | Dextrans | 1 | 2009 | 85 | 0.290 |
Why?
| | Prospective Studies | 6 | 2025 | 7805 | 0.290 |
Why?
| | Cystitis | 2 | 2005 | 23 | 0.280 |
Why?
| | Postoperative Complications | 5 | 2024 | 2831 | 0.280 |
Why?
| | Prune Belly Syndrome | 1 | 2007 | 8 | 0.280 |
Why?
| | Ethics, Professional | 1 | 2007 | 13 | 0.270 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 227 | 0.260 |
Why?
| | Diurnal Enuresis | 1 | 2006 | 1 | 0.260 |
Why?
| | Follow-Up Studies | 6 | 2019 | 5222 | 0.260 |
Why?
| | Patient Compliance | 2 | 2026 | 607 | 0.250 |
Why?
| | Competency-Based Education | 1 | 2007 | 75 | 0.250 |
Why?
| | Professional Competence | 1 | 2007 | 96 | 0.250 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 118 | 0.250 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 529 | 0.240 |
Why?
| | Urinary Catheterization | 1 | 2026 | 37 | 0.240 |
Why?
| | Mullerian Ducts | 1 | 2025 | 13 | 0.230 |
Why?
| | Congenital Abnormalities | 2 | 2025 | 105 | 0.230 |
Why?
| | Adenoma | 1 | 2007 | 217 | 0.230 |
Why?
| | Incidence | 4 | 2024 | 2809 | 0.230 |
Why?
| | Biocompatible Materials | 1 | 2009 | 431 | 0.220 |
Why?
| | Databases, Factual | 3 | 2022 | 1449 | 0.220 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2025 | 29 | 0.220 |
Why?
| | Feasibility Studies | 2 | 2022 | 1037 | 0.210 |
Why?
| | Neuromuscular Agents | 1 | 2005 | 44 | 0.210 |
Why?
| | Renal Artery | 1 | 2024 | 40 | 0.210 |
Why?
| | Dissent and Disputes | 1 | 2023 | 18 | 0.200 |
Why?
| | Abnormalities, Multiple | 1 | 2025 | 197 | 0.200 |
Why?
| | Muscle, Smooth | 2 | 2022 | 150 | 0.190 |
Why?
| | Vascular Resistance | 1 | 2024 | 364 | 0.190 |
Why?
| | Urinary Bladder Diseases | 1 | 2022 | 18 | 0.190 |
Why?
| | Drug Prescriptions | 1 | 2024 | 267 | 0.190 |
Why?
| | Duodenum | 1 | 2022 | 74 | 0.190 |
Why?
| | Patient Care | 1 | 2023 | 116 | 0.190 |
Why?
| | Propensity Score | 1 | 2024 | 337 | 0.190 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3345 | 0.190 |
Why?
| | United States | 9 | 2025 | 15298 | 0.190 |
Why?
| | Sexual Development | 1 | 2022 | 16 | 0.190 |
Why?
| | Laparoscopy | 2 | 2022 | 465 | 0.180 |
Why?
| | Ureter | 1 | 2022 | 35 | 0.180 |
Why?
| | Postoperative Period | 2 | 2020 | 359 | 0.180 |
Why?
| | Probability | 1 | 2022 | 307 | 0.180 |
Why?
| | Social Justice | 1 | 2022 | 84 | 0.180 |
Why?
| | Urination | 3 | 2014 | 48 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 321 | 0.180 |
Why?
| | Bacteremia | 1 | 2024 | 218 | 0.170 |
Why?
| | Injury Severity Score | 1 | 2023 | 570 | 0.170 |
Why?
| | Urography | 2 | 2014 | 19 | 0.170 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 93 | 0.170 |
Why?
| | Registries | 2 | 2022 | 2205 | 0.170 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 350 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 1075 | 0.170 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2025 | 347 | 0.170 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 539 | 0.170 |
Why?
| | Trauma Centers | 1 | 2023 | 453 | 0.170 |
Why?
| | Adenocarcinoma | 1 | 2008 | 897 | 0.170 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 245 | 0.160 |
Why?
| | Actins | 1 | 2022 | 426 | 0.160 |
Why?
| | Wounds, Nonpenetrating | 1 | 2023 | 309 | 0.160 |
Why?
| | Treatment Outcome | 6 | 2025 | 11216 | 0.160 |
Why?
| | Clinical Competence | 1 | 2008 | 1210 | 0.160 |
Why?
| | Cohort Studies | 4 | 2024 | 5809 | 0.160 |
Why?
| | Anti-Bacterial Agents | 3 | 2025 | 1866 | 0.160 |
Why?
| | Patient Portals | 1 | 2019 | 45 | 0.150 |
Why?
| | General Surgery | 2 | 2024 | 199 | 0.140 |
Why?
| | User-Computer Interface | 1 | 2019 | 163 | 0.140 |
Why?
| | Kidney Diseases | 1 | 2022 | 409 | 0.140 |
Why?
| | Bacteriuria | 1 | 2018 | 11 | 0.140 |
Why?
| | Ambulatory Care | 2 | 2022 | 592 | 0.140 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2018 | 32 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 626 | 0.140 |
Why?
| | Disorders of Sex Development | 1 | 2018 | 39 | 0.140 |
Why?
| | Renal Dialysis | 1 | 2022 | 458 | 0.130 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5948 | 0.130 |
Why?
| | Social Support | 1 | 2022 | 629 | 0.130 |
Why?
| | Cystostomy | 1 | 2017 | 11 | 0.130 |
Why?
| | Curriculum | 1 | 2024 | 1035 | 0.130 |
Why?
| | Risk Factors | 6 | 2026 | 10490 | 0.130 |
Why?
| | Adult | 9 | 2025 | 39319 | 0.130 |
Why?
| | Mass Screening | 1 | 2025 | 1309 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 822 | 0.120 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 17 | 0.120 |
Why?
| | Analgesia | 1 | 2017 | 104 | 0.120 |
Why?
| | Fetus | 1 | 2020 | 797 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1117 | 0.120 |
Why?
| | Perioperative Care | 1 | 2018 | 228 | 0.110 |
Why?
| | Global Health | 1 | 2018 | 384 | 0.110 |
Why?
| | Reoperation | 1 | 2018 | 599 | 0.110 |
Why?
| | Length of Stay | 3 | 2025 | 1265 | 0.110 |
Why?
| | Caregivers | 1 | 2022 | 940 | 0.100 |
Why?
| | Health Information Exchange | 1 | 2014 | 21 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 684 | 0.100 |
Why?
| | Cloaca | 1 | 2014 | 48 | 0.100 |
Why?
| | Age Factors | 3 | 2018 | 3295 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 594 | 0.100 |
Why?
| | Program Evaluation | 2 | 2008 | 919 | 0.100 |
Why?
| | Cystoscopy | 2 | 2011 | 21 | 0.090 |
Why?
| | Urinary Retention | 1 | 2011 | 23 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 329 | 0.080 |
Why?
| | Sex Factors | 3 | 2018 | 2055 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2904 | 0.080 |
Why?
| | Ureteroscopy | 1 | 2009 | 16 | 0.080 |
Why?
| | Injections | 1 | 2009 | 191 | 0.070 |
Why?
| | Electrocoagulation | 1 | 2007 | 35 | 0.070 |
Why?
| | Stomach | 1 | 2008 | 109 | 0.070 |
Why?
| | Logistic Models | 2 | 2026 | 2098 | 0.070 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 158 | 0.070 |
Why?
| | Young Adult | 4 | 2025 | 13727 | 0.060 |
Why?
| | Medical Staff, Hospital | 1 | 2007 | 81 | 0.060 |
Why?
| | Professional Role | 1 | 2007 | 164 | 0.060 |
Why?
| | Urothelium | 1 | 2005 | 36 | 0.060 |
Why?
| | Educational Measurement | 1 | 2008 | 318 | 0.060 |
Why?
| | Administration, Intravesical | 1 | 2005 | 15 | 0.060 |
Why?
| | Program Development | 1 | 2007 | 364 | 0.060 |
Why?
| | Biopsy | 1 | 2007 | 1073 | 0.050 |
Why?
| | Faculty, Medical | 1 | 2007 | 290 | 0.050 |
Why?
| | Colorado | 1 | 2014 | 4599 | 0.050 |
Why?
| | Phimosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Circumcision, Male | 1 | 2003 | 16 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4180 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2765 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 484 | 0.050 |
Why?
| | Treatment Failure | 1 | 2024 | 355 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2511 | 0.050 |
Why?
| | Disease Management | 1 | 2006 | 634 | 0.050 |
Why?
| | Career Choice | 1 | 2024 | 233 | 0.050 |
Why?
| | Chronic Disease | 2 | 2005 | 1807 | 0.050 |
Why?
| | Abortion, Induced | 1 | 2024 | 106 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3734 | 0.040 |
Why?
| | Advisory Committees | 1 | 2022 | 214 | 0.040 |
Why?
| | Rats | 2 | 2005 | 5556 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1820 | 0.040 |
Why?
| | Cryptorchidism | 1 | 2018 | 16 | 0.040 |
Why?
| | Urolithiasis | 1 | 2018 | 10 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2018 | 68 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 123 | 0.030 |
Why?
| | Urine | 1 | 2018 | 62 | 0.030 |
Why?
| | Stents | 1 | 2022 | 535 | 0.030 |
Why?
| | Constipation | 1 | 2018 | 96 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2264 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1505 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2210 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 118 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1241 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 35 | 0.020 |
Why?
| | Urodynamics | 1 | 2011 | 49 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3577 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3024 | 0.020 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2011 | 60 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4080 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2011 | 282 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1043 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1243 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2011 | 320 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6951 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2005 | 8 | 0.010 |
Why?
| | Animals | 2 | 2005 | 37328 | 0.010 |
Why?
| | Mechanoreceptors | 1 | 2005 | 17 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2005 | 34 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2005 | 68 | 0.010 |
Why?
| | Cyclophosphamide | 1 | 2005 | 257 | 0.010 |
Why?
| | Sensory Receptor Cells | 1 | 2005 | 101 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2005 | 430 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4414 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|